1. Home
  2. OXLCP vs SVA Comparison

OXLCP vs SVA Comparison

Compare OXLCP & SVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OXLCP
  • SVA
  • Stock Information
  • Founded
  • OXLCP N/A
  • SVA N/A
  • Country
  • OXLCP United States
  • SVA
  • Employees
  • OXLCP N/A
  • SVA 3261
  • Industry
  • OXLCP Investment Managers
  • SVA
  • Sector
  • OXLCP Finance
  • SVA
  • Exchange
  • OXLCP Nasdaq
  • SVA NYSE
  • Market Cap
  • OXLCP N/A
  • SVA N/A
  • IPO Year
  • OXLCP N/A
  • SVA N/A
  • Fundamental
  • Price
  • OXLCP $23.90
  • SVA $6.47
  • Analyst Decision
  • OXLCP
  • SVA
  • Analyst Count
  • OXLCP 0
  • SVA 0
  • Target Price
  • OXLCP N/A
  • SVA N/A
  • AVG Volume (30 Days)
  • OXLCP N/A
  • SVA N/A
  • Earning Date
  • OXLCP N/A
  • SVA N/A
  • Dividend Yield
  • OXLCP N/A
  • SVA N/A
  • EPS Growth
  • OXLCP N/A
  • SVA N/A
  • EPS
  • OXLCP N/A
  • SVA N/A
  • Revenue
  • OXLCP N/A
  • SVA N/A
  • Revenue This Year
  • OXLCP N/A
  • SVA N/A
  • Revenue Next Year
  • OXLCP N/A
  • SVA N/A
  • P/E Ratio
  • OXLCP N/A
  • SVA N/A
  • Revenue Growth
  • OXLCP N/A
  • SVA N/A
  • 52 Week Low
  • OXLCP N/A
  • SVA N/A
  • 52 Week High
  • OXLCP N/A
  • SVA N/A
  • Technical
  • Relative Strength Index (RSI)
  • OXLCP 37.45
  • SVA N/A
  • Support Level
  • OXLCP $23.78
  • SVA N/A
  • Resistance Level
  • OXLCP $24.20
  • SVA N/A
  • Average True Range (ATR)
  • OXLCP 0.08
  • SVA 0.00
  • MACD
  • OXLCP -0.03
  • SVA -0.41
  • Stochastic Oscillator
  • OXLCP 28.57
  • SVA 0.00

About OXLCP Oxford Lane Capital Corp.

Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.

About SVA SINOVAC BIOTECH LTD

Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.

Share on Social Networks: